QQ客服 官方微博 反馈留言

	Systemic immune-inflammation index (SII) is useful to predict survival outcomes in patients with surgically resected non-small cell lung cancer
	Guo, Wei; Cai, Songhua; Zhang, Fan; Shao, Fei; Zhang, Guochao; Zhou, Yang; Zhao, Liang; Tan, Fengwei; Gao, Shugeng; He, Jie
	2019
卷号	10期号:4页码:761-768
关键词	Neutrophil-lymphocyte ratio non-small cell lung cancer platelet-lymphocyte ratio prognosis systemic immune-inflammation index
ISSN号	1759-7706
DOI	10.1111/1759-7714.12995
URL标识	查看原文
收录类别	SCIE ; PUBMED
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6345087
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Guo, Wei,Cai, Songhua,Zhang, Fan,et al. Systemic immune-inflammation index (SII) is useful to predict survival outcomes in patients with surgically resected non-small cell lung cancer[J],2019,10(4):761-768.
APA	Guo, Wei.,Cai, Songhua.,Zhang, Fan.,Shao, Fei.,Zhang, Guochao.,...&He, Jie.(2019).Systemic immune-inflammation index (SII) is useful to predict survival outcomes in patients with surgically resected non-small cell lung cancer.,10(4),761-768.
MLA	Guo, Wei,et al."Systemic immune-inflammation index (SII) is useful to predict survival outcomes in patients with surgically resected non-small cell lung cancer".10.4(2019):761-768.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。